1. Home
  2. PYXS

PYXS

Pyxis Oncology Inc.

Logo Pyxis Oncology Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Founded: 2018 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 263.3M IPO Year: 2021
Target Price: $9.80 AVG Volume (30 days): 930.2K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.85 EPS Growth: N/A
52 Week Low/High: $1.35 - $6.85 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): -88.89%

Share on Social Networks: